alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
No. 53426.

protest 133686-K/1325 (Chicago).

#### J. E. Bernard & Co., Inc. *v.*United States,

Opinion by

Cole, J.

It was stipulated that the merchandise consists of ox gall and hog gall the same in all material respects as the substance passed upon in *G. D. Searle & Co.*v. *United States*(21 Cust. Ct. 112, C. D. 1138). The claim for free entry under paragraph 1669 was therefore sustained.
Exhibit 8.1

List of Subsidiaries of Crucell N.V. as of February 19, 2003

|Legal Entity                                                  |  | Country of registration |  
|------------------------------------------------------------- |  | ----------------------- | -
|100% subsidiary Crucell N.V.:
Crucell Holland B.V.
(Leiden)   |  | Netherlands             |  
|100% subsidiary Crucell Holland B.V.: U-BiSys B.V.
(Utrecht)  |  | Netherlands             |  
|20.8% subsidiary Crucell Holland B.V.
Galapagos Genomics N.V. |  | Belgium (Mechelen       | )

---

QuickLinks
# C_2018022EN.01001301.xml

| 22.1.2018 | EN | Official Journal of the European Union | C 22/13 |
| --- | --- | --- | --- |

22.1.2018

EN

Official Journal of the European Union

C 22/13

---

Judgment of the Court (Tenth Chamber) of 23 November 2017 (request for a preliminary ruling from the Tribunal Supremo — Spain) — Salvador Benjumea Bravo de Laguna v Esteban Torras Ferrazzuolo

(Case C-381/16) (1)

1

((Reference for a preliminary ruling - Regulation (EC) No 207/2009 - EU trade mark - Article 16 - Trade mark as an object of property - Dealing with EU trade marks as national trade marks - Article 18 - Transfer of a trade mark registered in the name of the agent or representative of the trade mark’s proprietor - National provision allowing the possibility of bringing an action for recovery of ownership of a national trade mark registered in fraud of the owner’s rights or in breach of a legal or contractual obligation - Whether compatible with Regulation No 207/2009))

(2018/C 022/16)

Language of the case: Spanish

Referring court

Referring court

Tribunal Supremo

Parties to the main proceedings

Parties to the main proceedings

Applicant: Salvador Benjumea Bravo de Laguna

Applicant:

Defendant: Esteban Torras Ferrazzuolo

Defendant:

Operative part of the judgment

Operative part of the judgment

Articles 16 and 18 of Council Regulation (EC) No 207/2009 of 26 February 2009 on the [European Union] trade mark must be interpreted as not precluding the application to an EU trade mark of a national provision, such as that at issue in the main proceedings, under which a person harmed, by the trade mark registration which was applied for in fraud of his rights or in breach of a legal or contractual obligation, is entitled to claim ownership of that trade mark, provided that the situation concerned does not fall within those covered by Article 18 of that regulation.

---

(1)  OJ C 335, 12.9.2016.

1

---
## RECEIVEf3

IDPPT CBIC**201~** 

### JUN 

## -5 AM fO: 

## 46

CBJC Control Number

May 22,2014

Director, Chemical Control Division

US Environmental Protection Agency

Office of Pollution Prevention and Toxics

EPA East

Room4146

1201 Constitution A venue, NW

Washington, DC 20004



### Re: EPA

- HQ- OPPT- 2003

- 0012 

# 360501 DuPont Chemicals and Fluoroproducts

Chambers Works

Deepwater, NJ 08023



### DuPont Chambers Works NJPDES Permit No. NJ0005100

PFOA Data Submittal- Outfall DSN662 Weekly Grab Samples

April 2014 Sample Data

Dear Chemical Control Division:

Attached please find summaries of PFOA analytical results for the DuPont Chambers Works

weekly, grab samples taken at internal outfall DSN662A in April2014. In accordance with the

current site NJPDES permit (NJ0005100, effective September 2011), these results are provided

to NJDEP on a monthly basis via electronic discharge monitoring reports. The enclosures

include two paper and two electronic copies of the analytical results from this monitoring period.

Sincerely, 

# ll#ft&tfY/A_

Albert Patrick O'Neill

Unit Manager-Site Manufacturing Systems/Fluoroproducts

DuPont Chambers Works

APO/clc

Enclosures. ·! Copy to:

Document Control Office

US Environmental Protection Agency

Office of Pollution Prevention and Toxics

EPA East

Room6428

1200 Pennsylvania A venue, NW

Washington, DC 20460

Ms. Susan Rosenwinkel (cover letter only)

Principal Environmental Engineer

NJDEP Division of Water Quality

Bureau of Water Surfacing

Mail Code 40 1-02B

401 

### E. State Street

P.O. Box420

Trenton, NJ 08625-0420AnalytePFOASampleiDDateTop(ft)Total(T)/Bottom(ft)unitsDiss.(D)Duplicate#ug/LTSummaryofAnalyticalResults662-April2014662-GRAB662-GRAB662-GRAB662-GRAB4/7/144/14/144/21/144/28/140000000011112.753.073.773.09PFOA=PerfluorooctanoicAcidug/L=microgramsperLiterug/L=microgramsperliterorpartsperbillion(ppb)LOQ-limitofquantification-0.100ug/LISampleswereanalyzedbyCriticalPathServicesLLC.Reportedresultsrepresentasingleanalysis,exceptforthesamplecollectedon4/28/14.Acceptableprecisionwasobtainedandthereportedresultforthesamplecollectedon4/28/14representstheaverageoflabduplicateresults.ITheNJDEPlabcertificationnumberforCriticalPathServicesLLCisPA072.<andNO=Non_detectatstatedreportinglimitPage1of1IIIi-Copyofcwk662grabresults_apr14.xls:Sheet15/21/20142:09PM
No. 54556.

#### August Bentkamp & Co. and Philip Porter, Inc. *v.*United States,

protests 142450-K and 142206-K (New York).

Opinion by

Johnson, J.

Following the authorities cited in Abstract 15400 the court dismissed the protests.
IN THE UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF PENNSYLVANIA

In re PHARMACY BENEFIT MANAGERS : Civil Action No. 06-1782

:

ANTITRUST LITIGATION :

_______________________________________

BRADY ENTERPRISES, INC., et al. :

:

Plaintiffs, :

:

v. : Civil Action No. 03-4730

:

MEDCO HEALTH SOLUTIONS, INC. :

:

Defendant. :

_______________________________________

NORTH JACKSON PHARMACY, INC. and :

C&C INC., d/b/a/ BIG C DISCOUNT DRUGS, :

:

Plaintiffs, :

:

v. : Civil Action No. 06-4305

:

CAREMARK RX INC., et al, :

:

Defendants. :

_______________________________________

NORTH JACKSON PHARMACY, INC., :

:

Plaintiff, :

:

v. : Civil Action No. 06-4114

:

EXPRESS SCRIPTS, INC., et al, :

:

Defendants. :

_______________________________________

Case 2:03-cv-04730-CDJ Document 157 Filed 01/18/17 Page 1 of 2
NORTH JACKSON PHARMACY, INC., :

:

Plaintiff, :

:

v. : Civil Action No. 06-4115

:

MEDCO HEALTH SOLUTIONS INC. :

:

Defendant. :

ORDER

AND NOW, this 18th day of January, 2017, IT IS HEREBY ORDERED AS 

FOLLOWS:

Plaintiff Brady Enterprises, Inc.’s Revised and Amended Motion for Class Certification 

(Civ. A. No. 03-4730, Docket Entry 77) is DENIED.

Plaintiff North Jackson Pharmacy Inc.’s Motion for Class Certification (Civ. A. No. 06-

4305, Docket Entry 67; Civ. A. No. 06-MD-1782, Docket Entries 180, 248) is DENIED.

Defendants Caremark Rx, Inc. and Caremark Inc.’s Daubert Motion to Exclude 

Plaintiffs’ Expert Testimony (Civ. A. No. 06-4305, Docket Entry 77; Civ. A. No. 06-MD-1782, 

Docket Entry 259) is GRANTED.

Defendant Express Scripts, Inc.’s Motion to Decertify Plaintiffs’ Class (Civ. A. No. 06-

4114, Docket Entry 2; Civ. A. No. 06-MD-1782, Docket Entry 22) is GRANTED.

BY THE COURT:

 

/s/ C. Darnell Jones, II

C. Darnell Jones, II J.

Case 2:03-cv-04730-CDJ Document 157 Filed 01/18/17 Page 2 of 2
Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Nutraceutical International Corporation (the "Company") for
the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Frank W. Gay II, Chairman of the Board and Chief Executive Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge:



/s/ FRANK W. GAY II Frank W. Gay II Chairman of the Board and Chief Executive Officer


Date:
April 28, 2011

CERTIFICATION PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Nutraceutical International Corporation (the "Company") for
the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Cory J. McQueen, Vice President and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



/s/ CORY J. MCQUEEN Cory J. McQueen Vice President and Chief Financial Officer


Date:
April 28, 2011

Signed
originals of these written statements required by Section 906 have been provided to the Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.

---



QuickLinks
EXHIBIT 99.4

CONSENT OF INDEPENDENT REGISTERED CHARTERED ACCOUNTANTS

We consent to the use of our reports dated February 24, 2010 relating to the consolidated financial statements of Enerplus
Resources Fund (which report expresses an unqualified opinion and includes a separate report titled Comments by Independent Registered Chartered Accountants on Canada-United States of America
Reporting Difference relating to changes in accounting principles) and the effectiveness of Enerplus Resources Fund's internal control over financial reporting appearing in this Annual Report on
Form 40-F of Enerplus Resources Fund for the year ended December 31, 2009.

Calgary, Canada
March 12, 2010

/s/ Deloitte & Touche LLP
Independent Registered Chartered Accountants


---



QuickLinks
Exhibit 32.1

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
   PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report of Second Stage Ventures, Inc. (the
"Company") on Form 10-KSB for the period ended September 30, 2003, as filed with
the  Securities  and  Exchange  Commission on the date hereof (the "Report"), I,
Zennie  Morris, Principal Executive Officer of the Company, certify, pursuant to
18  U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act  of  2002,  that:

1.  The  Report  fully complies with the requirements of Sections 13(a) or 15(d)
of  the  Securities  Exchange  Act  of  1934;  and

2.  The  information  contained  in  the Report fairly presents, in all material
respects,  the  financial  condition  and  results of operations of the Company.

Date:  December  24,  2003

                                                       /s/  Zennie  Morris
                                                 -------------------------------
                                                   Zennie  Morris,  President
                                                 (Principal  Executive  Officer)


<PAGE>
No. P68/132.

protests 59/25798, etc. (Philadelphia).

No. P68/133.

protests 63/13010, etc. (New York).

#### Gross Plumbing & Rubber Company et al. *v.*United States, Globe Importing Co. *v.*United States,

Ford, J.

In accordance with stipulation of counsel that the merchandise covered by the foregoing protests'consists of strainers in chief value of brass similar in all material respects to those the subject of Davies, *Turner & Company*v. *United States*(55 Cust. Ct. 488, Abstract 69651), the claim of the plaintiffs was sustained.
| 1.  | the      Report fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934; and                                     |
|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|     |                                                                                                                                                                |
| 2.       | the      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |

| March      31, 2008 |   | /s/      Niv Krikov——————————————Niv      KrikovTreasurer,      Chief Financial Officerand      Principal Accounting Officer |
|---------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Document

Exhibit 10.1




Summary of Base Salaries
for
Executive Officers of Park National Corporation


On December 8, 2020, the Compensation Committee of the Board of Directors of Park National Corporation (“Park”) approved the base salaries for the fiscal year ending December 31, 2021, for each of the executive officers of Park: (a) David L. Trautman, Chairman of the Board and Chief Executive Officer of each of Park and The Park National Bank, a subsidiary of Park (“PNB”); (b) Brady T. Burt, Chief Financial Officer, Secretary and Treasurer of Park and Senior Vice President and Chief Financial Officer of PNB; (c) Matthew R. Miller, President of each of Park and PNB; and (d) C. Daniel DeLawder, Chairman of the Executive Committee of each of the Park Board of Directors and the PNB Board of Directors, and a full-time executive employee of PNB.  Those base salaries are:


•David L. Trautman -- $785,000


•Brady T. Burt -- $375,000  


•Matthew R. Miller -- $575,000  


•C. Daniel DeLawder -- $287,500
Exhibit 32

Certification Pursuant to Section 1350 of
Chapter 63 of Title 18
of the United States Code

I, Robert E.
Busch, Chief Executive Officer and Chief Financial Officer of PSE&G
Transition Funding II LLC, to the best of my knowledge, certify that (i) the
Annual Report of PSE&G Transition Funding II LLC on Form 10-K for the year
ended December 31, 2005 (the Periodic Report) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and (ii) the information contained in the Periodic Report fairly presents, in
all material respects, the financial condition and results of operations of
PSE&G Transition Funding II LLC.

| |                                                       | 
| | ----------------------------------------------------- | 
| | /s/ Robert E.
  Busch                                
| |                                                       | 
| | Robert E. Busch                                      
| | Chief
  Executive Officer and Chief Financial Officer
| | March 20,
  2006                                     

---
[Federal Register Volume 88, Number 218 (Tuesday, November 14, 2023)]
[Notices]
[Page 77952]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25050]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[S-214-2023]


Foreign-Trade Zone 26; Application for Subzone; Helena 
Industries, LLC; Cordele, Georgia

    An application has been submitted to the Foreign-Trade Zones (FTZ) 
Board by Georgina Foreign-Trade Zone, Inc., grantee of FTZ 26, 
requesting subzone status for the facilities of Helena Industries, LLC, 
located in Cordele, Georgia. The application was submitted pursuant to 
the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 
81a-81u), and the regulations of the FTZ Board (15 CFR part 400). It 
was formally docketed on November 8, 2023.
    The proposed subzone would consist of the following sites: Site 1 
(33 acres) 434 Fenn Road, Cordele, Georgia; and, Site 2 (9.2 acres) 
1198 Highway 280, Cordele, Georgia. A notification of proposed 
production activity has been submitted and is being processed under 15 
CFR 400.37 (Doc. B-54-2023). The proposed subzone would be subject to 
the existing activation limit of FTZ 26.
    In accordance with the FTZ Board's regulations, Christopher Kemp of 
the FTZ Staff is designated examiner to review the application and make 
recommendations to the Executive Secretary.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary and sent to: 
<a href="/cdn-cgi/l/email-protection#94f2e0eed4e0e6f5f0f1baf3fbe2"><span class="__cf_email__" data-cfemail="ef899b95af9b9d8e8b8ac1888099">[email protected]</span></a>. The closing period for their receipt is December 26, 
2023. Rebuttal comments in response to material submitted during the 
foregoing period may be submitted during the subsequent 15-day period 
to January 8, 2024.
    A copy of the application will be available for public inspection 
in the ``Online FTZ Information Section'' section of the FTZ Board's 
website, which is accessible via www.trade.gov/ftz.
    For further information, contact Christopher Kemp at 
<a href="/cdn-cgi/l/email-protection#783b100a110b0c1708101d0a56331d1508380c0a191c1d561f170e"><span class="__cf_email__" data-cfemail="d695bea4bfa5a2b9a6beb3a4f89db3bba696a2a4b7b2b3f8b1b9a0">[email protected]</span></a>.

    Dated: November 8, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-25050 Filed 11-13-23; 8:45 am]
BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Document

EXHIBIT 10.36
Amendment No. 3
Pfizer Inc. Executive Severance Plan


*     *     *




(New material underlined; deletions crossed out)






Section 2.1(c) of Appendix A of the Pfizer Inc. Executive Severance Plan is amended to read as follows:




(c)    His or her Official Notification Date is on or after December 21, 2018 and on or before October 23, 202021, 2022 or his Date of Termination is on or before December 19, 2022. “Official Notification Date” means the date an eligible employee’s Notice Period begins.
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

JOHNNY VARNER and

LEISA VARNER

:

:

: CIVIL ACTION NO. 02-CV-4200

Plaintiffs, :

:

v. :

:

BAYER CORPORATION;

BAYER AG;

GLAXOSMITHKLINE, PLC;

GLAXOSMITHKLINE;

SMITHKLINE BEECHAM

:

:

:

:

:

ENTRY OF APPEARANCE

:

Defendants. :

ENTRY OF APPEARANCE

To the Clerk of the Court:

Kindly enter the appearances of Hope S. Freiwald, Aline Fairweather, Erin

Brennan and Kirstin J. Miller as attorneys for defendant GlaxoSmithKline PLC.

Respectfully Submitted,

_____________________________ _____________________________

Hope S. Freiwald Aline Fairweather

_____________________________ _____________________________

Erin Brennan Kirstin J. Miller

DECHERT PRICE & RHOADS

4000 Bell Atlantic Tower

1717 Arch Street

Philadelphia, PA 19103-2793

(215) 994-4000

Case 2:02-cv-04200-CG Document 6 Filed 09/11/2002 Page 1 of 1
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 965 Engrossed in House (EH)]

<DOC>
H. Res. 965

                In the House of Representatives, U. S.,

                                                         July 11, 2018.
    Resolved, That at any time after adoption of this resolution the Speaker 
may, pursuant to clause 2(b) of rule XVIII, declare the House resolved into the 
Committee of the Whole House on the state of the Union for consideration of the 
bill (H.R. 200) to amend the Magnuson-Stevens Fishery Conservation and 
Management Act to provide flexibility for fishery managers and stability for 
fishermen, and for other purposes. The first reading of the bill shall be 
dispensed with. All points of order against consideration of the bill are 
waived. General debate shall be confined to the bill and shall not exceed one 
hour equally divided and controlled by the chair and ranking minority member of 
the Committee on Natural Resources. After general debate the bill shall be 
considered for amendment under the five-minute rule. It shall be in order to 
consider as an original bill for the purpose of amendment under the five-minute 
rule the amendment in the nature of a substitute recommended by the Committee on 
Natural Resources now printed in the bill. The committee amendment in the nature 
of a substitute shall be considered as read. All points of order against the 
committee amendment in the nature of a substitute are waived. No amendment to 
the committee amendment in the nature of a substitute shall be in order except 
those printed in the report of the Committee on Rules accompanying this 
resolution. Each such amendment may be offered only in the order printed in the 
report, may be offered only by a Member designated in the report, shall be 
considered as read, shall be debatable for the time specified in the report 
equally divided and controlled by the proponent and an opponent, shall not be 
subject to amendment, and shall not be subject to a demand for division of the 
question in the House or in the Committee of the Whole. All points of order 
against such amendments are waived. At the conclusion of consideration of the 
bill for amendment the Committee shall rise and report the bill to the House 
with such amendments as may have been adopted. Any Member may demand a separate 
vote in the House on any amendment adopted in the Committee of the Whole to the 
bill or to the committee amendment in the nature of a substitute. The previous 
question shall be considered as ordered on the bill and amendments thereto to 
final passage without intervening motion except one motion to recommit with or 
without instructions.
            Attest:

                                                                          Clerk.
```
No. 61240.

protests 286267-K, etc. (New York).

#### Western European Import Co. *v.*United States,

Opinion by

Johnson, J.

In accordance with stipulation of counsel that certain items of the merchandise consist of figures the same in all material respects as *450those passed upon in *Wm. S. Pitcairn Corp.*v. *United States*(39 C. C. P. A. 15, C. A. D. 458), the claim of the plaintiff was sustained.
Ex.-99.1 a)

INDEPENDENT AUDITORS' REPORT

Cendant Mortgage Corporation:

We have examined management's assertion about Cendant Mortgage Corporation's
compliance with the minimum servicing standards identified in the Mortgage
Bankers Association of America's UNIFORM SINGLE ATTESTATION PROGRAM FOR MORTGAGE
BANKERS (USAP) as of and for the year ended December 31, 2000 included in the
accompanying management assertion. Management is responsible for Cendant
Mortgage Corporation's compliance with those minimum servicing standards. Our
responsibility is to express an opinion on management's assertion about the
entity's compliance based on our examination.

Our examination was made in accordance with standards established by the
American Institute of Certified Public Accountants and, accordingly, included
examining on a test basis, evidence about Cendant Mortgage Corporation's
compliance with the minimum servicing standards and performing such other
procedures as we considered necessary in the circumstances. We believe that our
examination provides a reasonable basis for our opinion. Our examination does
nut provide a legal determination on Cendant Mortgage Corporation's compliance
with the minimum servicing standards.

In our opinion, management's assertion that Cendant Mortgage Corporation
complied with the aforementioned minimum servicing standards as of and for the
year ended December 31, 2000, is fairly stated in all material respects.

/s/ Deloitte & Touche LLP

February 9, 2001
Before the Second Division,

June 16, 1943

No. 48397.

#### Protests 721731-G, etc., of Beacon Wiper Supply Co. et al. (Boston).

Opinion by

Kincheloe, J.

Following *United States*v. *Schapiro*(24 C. C. P. A. 343, T. D. 48771) and *J. Milton Hagy Waste Works*v. *United States*(2 Cust. Ct. 385, C. D. 162), and in accordance with stipulation of counsel that certain of the cotton rags are similar to those involved in the cited cases, the protests were sustained as to the percentage of rags which were the same as those held free as rags used chiefly for paper making in the *Schapiro*case, *supra,*and as set out in the , decision herein.